Day One Biopharmaceuticals, Inc. (DAWN) Earnings Call Transcripts

12 earnings calls from January 2022 to February 24, 2026

NasdaqGS US Health Care Biotechnology

About Day One Biopharmaceuticals, Inc.

Day One Biopharmaceuticals, Inc. (DAWN) is a publicly listed company in the Biotechnology industry, within the Health Care sector. It trades on NasdaqGS and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 12 calls on record spanning January 11, 2022 to February 24, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 12 Day One Biopharmaceuticals, Inc. earnings call transcripts on record, spanning January 11, 2022 to February 24, 2026. Based on this history, Day One Biopharmaceuticals, Inc. reports semi-annually. The most recent call on file is dated February 24, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
DAWN
Exchange
NasdaqGS
Country
US
Sector
Health Care
Industry
Biotechnology
Calls on record
12
First call
January 11, 2022
Most recent
February 24, 2026
Reporting cadence
semi-annually
Quarter Date
Q4 FY2025 Feb 24, 2026 Read transcript
Company Conference Presentations Jan 13, 2026 Read transcript
Q3 FY2025 Nov 4, 2025 Read transcript
Q2 FY2025 Aug 5, 2025 Read transcript
Company Conference Presentations Jun 10, 2025 Read transcript
Company Conference Presentations May 13, 2025 Read transcript
Q1 FY2025 May 6, 2025 Read transcript
Q4 FY2024 Feb 25, 2025 Read transcript
Company Conference Presentations Jan 13, 2025 Read transcript
Q3 FY2024 Oct 30, 2024 Read transcript
Special Calls Apr 24, 2024 Read transcript
Company Conference Presentations Jan 11, 2022 Read transcript